1. Home
  2. BLCO vs CLF Comparison

BLCO vs CLF Comparison

Compare BLCO & CLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • CLF
  • Stock Information
  • Founded
  • BLCO 1853
  • CLF 1847
  • Country
  • BLCO Canada
  • CLF United States
  • Employees
  • BLCO N/A
  • CLF N/A
  • Industry
  • BLCO Ophthalmic Goods
  • CLF Metal Mining
  • Sector
  • BLCO Health Care
  • CLF Basic Materials
  • Exchange
  • BLCO Nasdaq
  • CLF Nasdaq
  • Market Cap
  • BLCO 5.2B
  • CLF 5.6B
  • IPO Year
  • BLCO 2022
  • CLF N/A
  • Fundamental
  • Price
  • BLCO $15.61
  • CLF $10.07
  • Analyst Decision
  • BLCO Hold
  • CLF Hold
  • Analyst Count
  • BLCO 14
  • CLF 12
  • Target Price
  • BLCO $16.46
  • CLF $11.22
  • AVG Volume (30 Days)
  • BLCO 531.9K
  • CLF 37.9M
  • Earning Date
  • BLCO 10-29-2025
  • CLF 10-20-2025
  • Dividend Yield
  • BLCO N/A
  • CLF N/A
  • EPS Growth
  • BLCO N/A
  • CLF N/A
  • EPS
  • BLCO N/A
  • CLF N/A
  • Revenue
  • BLCO $4,976,000,000.00
  • CLF $18,622,000,000.00
  • Revenue This Year
  • BLCO $8.12
  • CLF $0.73
  • Revenue Next Year
  • BLCO $5.81
  • CLF $4.81
  • P/E Ratio
  • BLCO N/A
  • CLF N/A
  • Revenue Growth
  • BLCO 6.23
  • CLF N/A
  • 52 Week Low
  • BLCO $10.45
  • CLF $5.63
  • 52 Week High
  • BLCO $20.71
  • CLF $16.70
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 56.34
  • CLF 33.97
  • Support Level
  • BLCO $14.89
  • CLF $12.21
  • Resistance Level
  • BLCO $16.00
  • CLF $12.71
  • Average True Range (ATR)
  • BLCO 0.52
  • CLF 0.81
  • MACD
  • BLCO -0.00
  • CLF -0.49
  • Stochastic Oscillator
  • BLCO 72.14
  • CLF 0.52

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About CLF Cleveland-Cliffs Inc.

Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.

Share on Social Networks: